TOPLINE: Treatment with adalimumab improves anemia, thrombocytosis, and leukocytosis in patients with hidradenitis suppurativa (HS), in clinical responders and nonresponders. METHODOLOGY: HS is a chronic inflammatory skin condition characterized by a high inflammatory burden and hematologic abnormalities such as anemia, leukocytosis, and thrombocytosis. Immunomodulatory therapy was previously found to improve hematologic abnormalities in a small …
